首页 > 最新文献

Acta Gastroenterologica Latinoamericana最新文献

英文 中文
[Colonoscopic Findings in Patients with a Positive Fecal Occult Blood Test: A Descriptive Study]. [粪便隐血试验阳性患者的结肠镜检查结果:一项描述性研究]。
Q4 Medicine Pub Date : 2024-12-30 eCollection Date: 2024-10-01 DOI: 10.52787/agl.v54i4.443
Edison Javier Moreira Granda, Santiago Regnasco, Josefina Romero, Itatí Guerríeri, Susana Misino, Diego Gariglio, Bárbara Chiussi, Hernán Bracone, Emilia Saá

Introduction: Colorectal cancer is one of the most frequent neoplasms and a serious public health concern worldwide. In 2020, in Argentina, 15,605 new cases of colorectal cancer were registered and, in 2022, 7,217 deaths representing 12% of all deaths from malignant tumors. The National Program for the Prevention and Early Detection of Colorectal Cancer recommends that people between 50 and 75 years of age with no personal or family history of colorectal cancer, no history of inflammatory bowel disease, no suggestive symptoms, and no known risk factors should undergo biennial immunological fecal occult blood test. For at-risk groups, specific evaluations are performed based on their specific needs. A positive result of the immunologic fecal occult blood test requires a colonoscopy, the most sensitive test for early detection.

Aim: To assess the rate of TSOMF-I with a positive result. To describe the percentage of patients who undergo VCC after a positive TSOMF-I result. To assess the adenoma detection rate and prevalence of CRC in patients with TSOMF-I-positive.

Materials and methods: A retrospective analysis was perfomedr, in which data were collected from individuals between 50 and 75 years of age with positive immunologic fecal occult blood test and colonoscopies performed at Hospital Pirovano, Ciudad Autónoma de Buenos Aires, from January 1, 2020 to January 1, 2024.

Results: A total of 717 patients were evaluated. A positive result on immunologic fecal occult blood test was observed in 21.6% (n=155) of the cohort, but only 42.6% (n=66) underwent colonoscopy. Findings were identified in 80% of cases, predominantly polyps (36.4%), internal hemorrhoids (34.8%), diverticulosis (18.1%) and angiectasis (4.5%). The prevalence of colorectal cancer was 3%, with an adenoma detection rate of 33.3%.

Conclusion: This study showed a high prevalence of colorectal lesions, including adenomas and colorectal cancer, with figures that resemble those published by other international studies. The results obtained reflect the efficacy of immunological fecal occult blood test screening to identify relevant colorectal lesions. A key finding was that less than half of the patients with positive immunological faecal occult blood test underwent subsequent colonoscopy, which indicates the existence of important barriers to access to this study in our setting and reinforces the need to implement strategies to increase it. These findings are crucial to optimize colorectal cancer screening programs in Argentina, adapting them to the needs of the local population and improving public health outcomes.

结直肠癌是世界上最常见的肿瘤之一,也是一个严重的公共卫生问题。2020年,阿根廷登记了15 605例结直肠癌新病例,2022年有7 217例死亡,占恶性肿瘤死亡总数的12%。美国国家预防和早期发现结直肠癌计划建议,年龄在50 - 75岁之间,没有个人或家族结直肠癌病史,没有炎症性肠病病史,没有提示症状,没有已知危险因素的人应进行两年一次的免疫粪便潜血检查。对于高危人群,根据他们的具体需要进行具体评估。免疫粪便隐血检查阳性结果需要结肠镜检查,这是早期发现的最敏感的检查。目的:评价tsomf - 1阳性检出率。描述TSOMF-I阳性后接受VCC的患者百分比。目的评估tsomf - i阳性患者结直肠癌的腺瘤检出率和患病率。材料和方法:回顾性分析收集2020年1月1日至2024年1月1日在布宜诺斯艾利萨市Autónoma Pirovano医院进行免疫粪便隐血检查和结肠镜检查阳性的50 ~ 75岁患者的数据。结果:共评估717例患者。21.6% (n=155)的患者进行了免疫粪便隐血检查,但只有42.6% (n=66)的患者进行了结肠镜检查。在80%的病例中发现,主要是息肉(36.4%)、内痔(34.8%)、憩室病(18.1%)和血管扩张(4.5%)。结直肠癌患病率为3%,腺瘤检出率为33.3%。结论:本研究显示,包括腺瘤和结直肠癌在内的结直肠病变的患病率较高,其数据与其他国际研究报告的数据相似。所获得的结果反映了免疫粪便潜血检查筛查识别相关结直肠病变的有效性。一个关键的发现是,只有不到一半的免疫粪便隐血检查阳性的患者接受了随后的结肠镜检查,这表明在我们的环境中存在重要的障碍,并加强了实施策略来增加这种障碍的必要性。这些发现对于优化阿根廷的结直肠癌筛查项目,使其适应当地人口的需求并改善公共卫生结果至关重要。
{"title":"[Colonoscopic Findings in Patients with a Positive Fecal Occult Blood Test: A Descriptive Study].","authors":"Edison Javier Moreira Granda, Santiago Regnasco, Josefina Romero, Itatí Guerríeri, Susana Misino, Diego Gariglio, Bárbara Chiussi, Hernán Bracone, Emilia Saá","doi":"10.52787/agl.v54i4.443","DOIUrl":"10.52787/agl.v54i4.443","url":null,"abstract":"<p><strong>Introduction: </strong>Colorectal cancer is one of the most frequent neoplasms and a serious public health concern worldwide. In 2020, in Argentina, 15,605 new cases of colorectal cancer were registered and, in 2022, 7,217 deaths representing 12% of all deaths from malignant tumors. The National Program for the Prevention and Early Detection of Colorectal Cancer recommends that people between 50 and 75 years of age with no personal or family history of colorectal cancer, no history of inflammatory bowel disease, no suggestive symptoms, and no known risk factors should undergo biennial immunological fecal occult blood test. For at-risk groups, specific evaluations are performed based on their specific needs. A positive result of the immunologic fecal occult blood test requires a colonoscopy, the most sensitive test for early detection.</p><p><strong>Aim: </strong>To assess the rate of TSOMF-I with a positive result. To describe the percentage of patients who undergo VCC after a positive TSOMF-I result. To assess the adenoma detection rate and prevalence of CRC in patients with TSOMF-I-positive.</p><p><strong>Materials and methods: </strong>A retrospective analysis was perfomedr, in which data were collected from individuals between 50 and 75 years of age with positive immunologic fecal occult blood test and colonoscopies performed at Hospital Pirovano, Ciudad Autónoma de Buenos Aires, from January 1, 2020 to January 1, 2024.</p><p><strong>Results: </strong>A total of 717 patients were evaluated. A positive result on immunologic fecal occult blood test was observed in 21.6% (n=155) of the cohort, but only 42.6% (n=66) underwent colonoscopy. Findings were identified in 80% of cases, predominantly polyps (36.4%), internal hemorrhoids (34.8%), diverticulosis (18.1%) and angiectasis (4.5%). The prevalence of colorectal cancer was 3%, with an adenoma detection rate of 33.3%.</p><p><strong>Conclusion: </strong>This study showed a high prevalence of colorectal lesions, including adenomas and colorectal cancer, with figures that resemble those published by other international studies. The results obtained reflect the efficacy of immunological fecal occult blood test screening to identify relevant colorectal lesions. A key finding was that less than half of the patients with positive immunological faecal occult blood test underwent subsequent colonoscopy, which indicates the existence of important barriers to access to this study in our setting and reinforces the need to implement strategies to increase it. These findings are crucial to optimize colorectal cancer screening programs in Argentina, adapting them to the needs of the local population and improving public health outcomes.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 4","pages":"318-326"},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12120945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tofacitinib as Rescue Therapy in a Patient with Severe Acute Ulcerative Colitis Refractory to Corticosteroids and Infliximab: A Case Report]. [托法替尼作为皮质类固醇和英夫利昔单抗难治性严重急性溃疡性结肠炎患者的抢救治疗:1例报告]。
Q4 Medicine Pub Date : 2024-12-30 eCollection Date: 2024-10-01 DOI: 10.52787/agl.v54i4.406
Camila Brizhttps, Agustín Di Santo, Federico Cassella

Ulcerative colitis is a chronic inflammatory disease that can present with varying degrees of severity. The severe acute form occurs in up to 25% of patients, and its diagnosis is important for timely treatment and detection of complications. To date, clinical practice guidelines suggest first-line treatment with corticosteroids, second-line treatment with infliximab or cyclosporine, and surgical resolution in case of therapeutic failure. We present the clinical case of a 22-year-old female patient with severe acute ulcerative colitis as disease debut, refractory to treatment with corticosteroids and infliximab, who was treated with tofacitinib as rescue therapy.

溃疡性结肠炎是一种慢性炎症性疾病,可呈现不同程度的严重程度。严重急性形式发生在高达25%的患者中,其诊断对于及时治疗和发现并发症非常重要。迄今为止,临床实践指南建议用皮质类固醇进行一线治疗,用英夫利昔单抗或环孢素进行二线治疗,治疗失败时进行手术治疗。我们报告一例22岁的女性重症急性溃疡性结肠炎首发病例,皮质类固醇和英夫利昔单抗治疗难治性,采用托法替尼作为抢救治疗。
{"title":"[Tofacitinib as Rescue Therapy in a Patient with Severe Acute Ulcerative Colitis Refractory to Corticosteroids and Infliximab: A Case Report].","authors":"Camila Brizhttps, Agustín Di Santo, Federico Cassella","doi":"10.52787/agl.v54i4.406","DOIUrl":"10.52787/agl.v54i4.406","url":null,"abstract":"<p><p>Ulcerative colitis is a chronic inflammatory disease that can present with varying degrees of severity. The severe acute form occurs in up to 25% of patients, and its diagnosis is important for timely treatment and detection of complications. To date, clinical practice guidelines suggest first-line treatment with corticosteroids, second-line treatment with infliximab or cyclosporine, and surgical resolution in case of therapeutic failure. We present the clinical case of a 22-year-old female patient with severe acute ulcerative colitis as disease debut, refractory to treatment with corticosteroids and infliximab, who was treated with tofacitinib as rescue therapy.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 4","pages":"336-340"},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12310250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Between Guidelines and Gases: A Multicenter Evaluation of the Methodology, Diagnostic Accuracy and Quality of Hydrogen and Methane Breath Tests in Argentina]. [在指南和气体之间:阿根廷氢和甲烷呼吸试验方法、诊断准确性和质量的多中心评价]。
Q4 Medicine Pub Date : 2024-12-30 eCollection Date: 2024-10-01 DOI: 10.52787/agl.v54i4.449
Sofía Navar, Lisandro Pereyra, Juan Pablo Stefanolo, Leandro Steinberg, Federico Bentolila, Sergio Barril, Julieta Alonso, Andrés Palazzo, Abel Novillo, Nicolas Rovati, Vivian Vizcay, Federico Meuli, Deborah Balfour, Diego Guillermo Alonso

Introduction: The breath test is currently the most widely used tool for diagnosing small intestinal bacterial overgrowth. The rising prevalence of this condition has led to increased test utilization. However, concerns remain regarding its im plementation, including adherence to international guidelines related to methodology, diagnostic interpretation, and report quality.

Aim: To assess the methodology, report quality, and diagnostic accuracy of breath tests for small intestinal bacterial overgrowth in Argentina, based on international guidelines.

Material and methods: A multicenter observational study included 210 breath test reports from 8 centers across differ ent geographic regions of Argentina. The methodology used for test performance and report quality was evaluated based on 13 predefined criteria. Additionally, the concordance between the diagnoses reported by centers and those determined by an expert based on international guidelines was analyzed.

Results: Significant heterogeneity in methodology and low ad herence to international guidelines were observed. Among the studies, 89% measured only H2, while 11% included CH4. Combined sampling intervals were used in 53%, and only 19% reached 180 minutes, with nearly 20% classified as in complete: only 10% specified diagnostic thresholds, and just 4% aligned with current guidelines. Diagnostic concordance was 87% for small intestinal bacterial overgrowth and 73% for intestinal methanogen overgrowth, with an average of 5 out of 13 quality criteria met.

Conclusions: This study underscores the need to standardize breath test methodology and enhance adherence to international guidelines. Efforts should focus on improving report quality, unifying methodology, and increasing diagnostic accuracy for small intestinal bacterial overgrowth in Argentina.

呼气试验是目前应用最广泛的诊断小肠细菌过度生长的工具。这种情况的日益流行导致了测试使用率的增加。然而,对其实施的关注仍然存在,包括遵守与方法、诊断解释和报告质量有关的国际准则。目的:根据国际指南,评估阿根廷小肠细菌过度生长呼吸试验的方法、报告质量和诊断准确性。材料和方法:一项多中心观察性研究包括来自阿根廷不同地理区域8个中心的210份呼吸测试报告。用于测试性能和报告质量的方法基于13个预定义的标准进行评估。此外,中心报告的诊断与专家根据国际指南确定的诊断之间的一致性进行了分析。结果:观察到研究方法的显著异质性和对国际指南的低依从性。在这些研究中,89%只测量了H2, 11%测量了CH4。53%的患者使用了联合抽样间隔,只有19%的患者达到了180分钟,近20%的患者被归类为完全;只有10%的患者指定了诊断阈值,只有4%的患者符合当前的指南。小肠细菌过度生长的诊断符合率为87%,肠道产甲烷菌过度生长的诊断符合率为73%,13项质量标准中平均有5项符合。结论:本研究强调了标准化呼吸测试方法和加强对国际指南的遵守的必要性。努力应集中在提高报告质量、统一方法和提高阿根廷小肠细菌过度生长的诊断准确性。
{"title":"[Between Guidelines and Gases: A Multicenter Evaluation of the Methodology, Diagnostic Accuracy and Quality of Hydrogen and Methane Breath Tests in Argentina].","authors":"Sofía Navar, Lisandro Pereyra, Juan Pablo Stefanolo, Leandro Steinberg, Federico Bentolila, Sergio Barril, Julieta Alonso, Andrés Palazzo, Abel Novillo, Nicolas Rovati, Vivian Vizcay, Federico Meuli, Deborah Balfour, Diego Guillermo Alonso","doi":"10.52787/agl.v54i4.449","DOIUrl":"10.52787/agl.v54i4.449","url":null,"abstract":"<p><strong>Introduction: </strong>The breath test is currently the most widely used tool for diagnosing small intestinal bacterial overgrowth. The rising prevalence of this condition has led to increased test utilization. However, concerns remain regarding its im plementation, including adherence to international guidelines related to methodology, diagnostic interpretation, and report quality.</p><p><strong>Aim: </strong>To assess the methodology, report quality, and diagnostic accuracy of breath tests for small intestinal bacterial overgrowth in Argentina, based on international guidelines.</p><p><strong>Material and methods: </strong>A multicenter observational study included 210 breath test reports from 8 centers across differ ent geographic regions of Argentina. The methodology used for test performance and report quality was evaluated based on 13 predefined criteria. Additionally, the concordance between the diagnoses reported by centers and those determined by an expert based on international guidelines was analyzed.</p><p><strong>Results: </strong>Significant heterogeneity in methodology and low ad herence to international guidelines were observed. Among the studies, 89% measured only H<sub>2</sub>, while 11% included CH<sub>4</sub>. Combined sampling intervals were used in 53%, and only 19% reached 180 minutes, with nearly 20% classified as in complete: only 10% specified diagnostic thresholds, and just 4% aligned with current guidelines. Diagnostic concordance was 87% for small intestinal bacterial overgrowth and 73% for intestinal methanogen overgrowth, with an average of 5 out of 13 quality criteria met.</p><p><strong>Conclusions: </strong>This study underscores the need to standardize breath test methodology and enhance adherence to international guidelines. Efforts should focus on improving report quality, unifying methodology, and increasing diagnostic accuracy for small intestinal bacterial overgrowth in Argentina.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 4","pages":"327-335"},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12120959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ganglioneuroma of the Small Intestine Mimicking Crohn's Disease]. [模拟克罗恩病的小肠神经节神经瘤]。
Q4 Medicine Pub Date : 2024-12-30 eCollection Date: 2024-10-01 DOI: 10.52787/agl.v54i4.411
Paul Eduardo Lada, Paula Frávega, Fabián Caballero, Martín Sánchez, Christian Janikow, Julián Martínez Peluaga, Selene Molina, Florencia Matcosky, María Rosa Defago

Introduction: Intestinal ganglioneuromatosis is a rare benign neoplastic disease. It is usually described in children, in association with multiple endocrine neoplasia type 2b and neurofibromatosis type 1. Ganglioneuromatosis is rare in adults, where it usually occurs sporadically and in isolation.

Case report: We present a patient with intestinal ganglioneuromatosis in whom the initial clinical and radiographic findings simulated Crohn's disease. A small bowel resection was performed due to endoscopic capsule occlusion. The immunohistochemical study of the resected segment suggested the diagnosis of small bowel ganglioneuroma.

Conclusion: The clinical presentation of intestinal ganglioneuromatosis is variable. The patient may be oligosymptomatic or have an atypical presentation. This diagnosis should be considered when the most common causes of iron deficiency anemia have been excluded. Definitive diagnosis is possible after resection and pathologic analysis of the segment involved.

肠神经节神经瘤病是一种罕见的良性肿瘤疾病。它通常发生在儿童,与多发性内分泌瘤2b型和1型神经纤维瘤病有关。神经节神经瘤病在成人中是罕见的,它通常是零星和孤立发生的。病例报告:我们提出了一个病人肠神经节神经瘤病在最初的临床和影像学表现模拟克罗恩病。由于内窥镜囊闭塞,行小肠切除术。切除节段的免疫组化检查提示诊断为小肠神经节神经瘤。结论:肠神经节神经瘤病临床表现多样。患者可能无症状或表现不典型。当排除缺铁性贫血最常见的病因时,应考虑此诊断。明确的诊断是可能的切除和病理分析后,涉及节段。
{"title":"[Ganglioneuroma of the Small Intestine Mimicking Crohn's Disease].","authors":"Paul Eduardo Lada, Paula Frávega, Fabián Caballero, Martín Sánchez, Christian Janikow, Julián Martínez Peluaga, Selene Molina, Florencia Matcosky, María Rosa Defago","doi":"10.52787/agl.v54i4.411","DOIUrl":"10.52787/agl.v54i4.411","url":null,"abstract":"<p><strong>Introduction: </strong>Intestinal ganglioneuromatosis is a rare benign neoplastic disease. It is usually described in children, in association with multiple endocrine neoplasia type 2b and neurofibromatosis type 1. Ganglioneuromatosis is rare in adults, where it usually occurs sporadically and in isolation.</p><p><strong>Case report: </strong>We present a patient with intestinal ganglioneuromatosis in whom the initial clinical and radiographic findings simulated Crohn's disease. A small bowel resection was performed due to endoscopic capsule occlusion. The immunohistochemical study of the resected segment suggested the diagnosis of small bowel ganglioneuroma.</p><p><strong>Conclusion: </strong>The clinical presentation of intestinal ganglioneuromatosis is variable. The patient may be oligosymptomatic or have an atypical presentation. This diagnosis should be considered when the most common causes of iron deficiency anemia have been excluded. Definitive diagnosis is possible after resection and pathologic analysis of the segment involved.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 4","pages":"341-345"},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12310258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[[Evidence in Times of Artificial Intelligence]]. 人工智能时代的证据[j]。
Q4 Medicine Pub Date : 2024-12-30 eCollection Date: 2024-10-01 DOI: 10.52787/agl.v54i4.453
Diego Pérez de Arenaza
{"title":"[[Evidence in Times of Artificial Intelligence]].","authors":"Diego Pérez de Arenaza","doi":"10.52787/agl.v54i4.453","DOIUrl":"10.52787/agl.v54i4.453","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 4","pages":"293-295"},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12310251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Gastric Cancer Prevention: Latin American Context and Experience]. [胃癌预防:拉丁美洲的背景和经验]。
Q4 Medicine Pub Date : 2024-12-30 eCollection Date: 2024-10-01 DOI: 10.52787/agl.v54i4.456
Oscar Laudanno, Arnoldo Riquelme, Patricio Medel-Jara

Gastric cancer is a multifactorial disease, and chronic Helicobacter pylori infection is one of its main causes. It receives little attention in the West, with few preventive policies, especially in countries such as Argentina, which is considered 'low risk.' But both in Argentina and in the United States, the population is heterogeneous, with permanent immigration from countries with high or intermediate risk, with the highest susceptibility in the male population. It is estimated that the incidence will increase due to the aging of the population. In recent years, new evidence for its prevention has emerged. The main strategy for primary prevention is the eradication of Helicobacter pylori, while secondary prevention for heterogeneous countries such as Argentina is based on the identification of risk groups, particularly those with the so-called precursor lesions of gastric cancer. This narrative review explores all these strategies with a 'strong bias' towards the situation in Argentina, Chile and Latin America.

胃癌是一种多因素疾病,慢性幽门螺杆菌感染是其主要病因之一。它在西方很少受到关注,几乎没有预防政策,特别是在阿根廷等被认为是“低风险”的国家。但无论是在阿根廷还是在美国,人口都是异质的,来自高风险或中等风险国家的永久移民,男性人口的易感性最高。据估计,由于人口老龄化,发病率将会增加。近年来,出现了预防该病的新证据。一级预防的主要战略是根除幽门螺杆菌,而阿根廷等异质性国家的二级预防是基于对危险群体的识别,特别是那些具有所谓的胃癌前驱病变的人群。这篇叙述性综述探讨了所有这些战略,并“强烈偏向”于阿根廷、智利和拉丁美洲的局势。
{"title":"[Gastric Cancer Prevention: Latin American Context and Experience].","authors":"Oscar Laudanno, Arnoldo Riquelme, Patricio Medel-Jara","doi":"10.52787/agl.v54i4.456","DOIUrl":"10.52787/agl.v54i4.456","url":null,"abstract":"<p><p>Gastric cancer is a multifactorial disease, and chronic Helicobacter pylori infection is one of its main causes. It receives little attention in the West, with few preventive policies, especially in countries such as Argentina, which is considered 'low risk.' But both in Argentina and in the United States, the population is heterogeneous, with permanent immigration from countries with high or intermediate risk, with the highest susceptibility in the male population. It is estimated that the incidence will increase due to the aging of the population. In recent years, new evidence for its prevention has emerged. The main strategy for primary prevention is the eradication of Helicobacter pylori, while secondary prevention for heterogeneous countries such as Argentina is based on the identification of risk groups, particularly those with the so-called precursor lesions of gastric cancer. This narrative review explores all these strategies with a 'strong bias' towards the situation in Argentina, Chile and Latin America.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 4","pages":"299-309"},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12120948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Utility of FLIP Technology in the Diagnosis of Patients with Esophageal Dysphagia: A Case Series]. [FLIP技术在食管吞咽困难患者诊断中的应用:一个病例系列]。
Q4 Medicine Pub Date : 2024-12-30 eCollection Date: 2024-10-01 DOI: 10.52787/agl.v54i4.448
Mauro Santana, Fernanda Gutiérrez, Carolina Acquafresca, Adriana Tevez, Esteban GonzalezBallerga, Juan Ignacio Olmos

Dysphagia is the sensation of difficulty in the passage of swallowed material from the mouth to the stomac, and is a common symptom in adults. It can indicate a variety of conditions, ranging from severe etiologies to oropharyngeal dysfunctions that carry a risk of aspiration. Esophageal dysphagia is specifically related to disorders affecting the passage of the bolus through the esophagus, which may be caused by structural abnormalities or motility problems. To address esophageal dysphagia, study methods include upper digestive videoendoscopy and esophageal barium transit, the former being the recommended initial study. High-resolution esophageal manometry is essential for evaluating motility disorders, with the Chicago Classification (CCv4.0) used to categorize these disorders. Although high-resolution manometry is the gold standard, additional studies may be required if the results are uncertain. EndoFLIP has recently enabled more precise assessment of the esophageal function and the esophagogastric junction, providing three-dimensional information about the esophageal lumen, measuring areas and distensibility, which is useful for diagnosing disorders such as non-obstructive esophageal dysphagia and assessing the efficacy of treatments in the postoperative period. In the following work, we describe our preliminary experience in the use of this technology through a case series.

吞咽困难是指吞咽的物质难以从口腔进入胃部的感觉,是成人的常见症状。它可以表明多种情况,从严重的病因到有误吸风险的口咽功能障碍。食道吞咽困难与影响丸通过食道的障碍有关,这可能是由结构异常或运动性问题引起的。为了解决食管吞咽困难,研究方法包括上消化道内镜和食管钡转运,前者是推荐的初始研究。高分辨率食管测压对于评估运动障碍至关重要,芝加哥分类(CCv4.0)用于对这些疾病进行分类。虽然高分辨率测压法是金标准,但如果结果不确定,可能需要进行额外的研究。EndoFLIP最近能够更精确地评估食管功能和食管胃交界处,提供有关食管腔的三维信息,测量面积和扩张率,这对于诊断非阻塞性食管吞咽困难等疾病和评估术后治疗效果非常有用。在接下来的工作中,我们将通过一系列案例描述我们在使用该技术方面的初步经验。
{"title":"[Utility of FLIP Technology in the Diagnosis of Patients with Esophageal Dysphagia: A Case Series].","authors":"Mauro Santana, Fernanda Gutiérrez, Carolina Acquafresca, Adriana Tevez, Esteban GonzalezBallerga, Juan Ignacio Olmos","doi":"10.52787/agl.v54i4.448","DOIUrl":"10.52787/agl.v54i4.448","url":null,"abstract":"<p><p>Dysphagia is the sensation of difficulty in the passage of swallowed material from the mouth to the stomac, and is a common symptom in adults. It can indicate a variety of conditions, ranging from severe etiologies to oropharyngeal dysfunctions that carry a risk of aspiration. Esophageal dysphagia is specifically related to disorders affecting the passage of the bolus through the esophagus, which may be caused by structural abnormalities or motility problems. To address esophageal dysphagia, study methods include upper digestive videoendoscopy and esophageal barium transit, the former being the recommended initial study. High-resolution esophageal manometry is essential for evaluating motility disorders, with the Chicago Classification (CCv4.0) used to categorize these disorders. Although high-resolution manometry is the gold standard, additional studies may be required if the results are uncertain. EndoFLIP has recently enabled more precise assessment of the esophageal function and the esophagogastric junction, providing three-dimensional information about the esophageal lumen, measuring areas and distensibility, which is useful for diagnosing disorders such as non-obstructive esophageal dysphagia and assessing the efficacy of treatments in the postoperative period. In the following work, we describe our preliminary experience in the use of this technology through a case series.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 4","pages":"311-317"},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12120957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Minimal Sedation in Endoscopic Retrograde Cholangiopancreatography Supervised by Endoscopists: Experience in Venezuelan Patients]. [内镜医师监督下逆行胆管造影术的最小镇静:委内瑞拉患者的经验]。
Q4 Medicine Pub Date : 2024-09-30 eCollection Date: 2024-07-01 DOI: 10.52787/agl.v54i3.433
Yhonny José Castillo Arrieta, Diego Alejandro Castillo Ayala, Frank Figueroa Castillo, Luis Eduardo Traviezo Valles

Introduction: The use of sedation in digestive endoscopy, particularly in endoscopic retrograde cholangiopancreatography, improves patient tolerance to the procedure and facilitate optimal endoscopic examination conditions, thereby achieving the desired diagnostic and therapeutic effect. Fentanyl and diazepam have been used for years as intravenous medication for upper gastrointestinal endoscopy.

Objective: To evaluate the safety of sedation with diazepam and fentanyl, under the supervision of endoscopists, during endoscopic retrograde cholangiopancreatography.

Material and methods: Descriptive, cross-sectional and prospective study conducted in patients who underwent endoscopic retrograde cholangiopancreatography under sedation with diazepam (5 to 15 mg) and fentanyl (25 to 50 µg) between July 2014 and June 2024. Oxygen saturation, blood pressure and heart rate were monitored to determine the occurrence of adverse events attributable to sedation.

Results: 12,686 patients were studied with an average age of 52.5 years. Hypoxemia was the most frequent complication (85 patients, 0.7%), followed by bradycardia (54 patients,0.4%) and arterial hypotension (41 patients, 0.3%).

Conclusions: Diazepam and fentanyl, administered by trained endoscopist physician and nurse, represent a safe anesthetic alternative for endoscopic retrograde cholangiopancreatography. It allows procedures to be performed outside the operating room, thereby reducing costs.

在消化内镜,特别是内镜逆行胰胆管造影中使用镇静,可以提高患者对手术的耐受性,促进最佳的内镜检查条件,从而达到预期的诊断和治疗效果。芬太尼和地西泮多年来一直被用作上消化道内窥镜的静脉注射药物。目的:评价内镜下逆行胆管造影时安定和芬太尼镇静的安全性。材料与方法:对2014年7月至2024年6月间在安定(5 ~ 15mg)和芬太尼(25 ~ 50µg)镇静下行内窥镜逆行胆管造影的患者进行描述性、横断面和前瞻性研究。监测血氧饱和度、血压和心率,以确定镇静引起的不良事件的发生。结果:共纳入12686例患者,平均年龄52.5岁。低氧血症是最常见的并发症(85例,0.7%),其次是心动过缓(54例,0.4%)和动脉低血压(41例,0.3%)。结论:地西泮和芬太尼,由训练有素的内窥镜医师和护士给药,是内窥镜逆行胆管造影的一种安全的麻醉选择。它允许手术在手术室外进行,从而降低了成本。
{"title":"[Minimal Sedation in Endoscopic Retrograde Cholangiopancreatography Supervised by Endoscopists: Experience in Venezuelan Patients].","authors":"Yhonny José Castillo Arrieta, Diego Alejandro Castillo Ayala, Frank Figueroa Castillo, Luis Eduardo Traviezo Valles","doi":"10.52787/agl.v54i3.433","DOIUrl":"10.52787/agl.v54i3.433","url":null,"abstract":"<p><strong>Introduction: </strong>The use of sedation in digestive endoscopy, particularly in endoscopic retrograde cholangiopancreatography, improves patient tolerance to the procedure and facilitate optimal endoscopic examination conditions, thereby achieving the desired diagnostic and therapeutic effect. Fentanyl and diazepam have been used for years as intravenous medication for upper gastrointestinal endoscopy.</p><p><strong>Objective: </strong>To evaluate the safety of sedation with diazepam and fentanyl, under the supervision of endoscopists, during endoscopic retrograde cholangiopancreatography.</p><p><strong>Material and methods: </strong>Descriptive, cross-sectional and prospective study conducted in patients who underwent endoscopic retrograde cholangiopancreatography under sedation with diazepam (5 to 15 mg) and fentanyl (25 to 50 µg) between July 2014 and June 2024. Oxygen saturation, blood pressure and heart rate were monitored to determine the occurrence of adverse events attributable to sedation.</p><p><strong>Results: </strong>12,686 patients were studied with an average age of 52.5 years. Hypoxemia was the most frequent complication (85 patients, 0.7%), followed by bradycardia (54 patients,0.4%) and arterial hypotension (41 patients, 0.3%).</p><p><strong>Conclusions: </strong>Diazepam and fentanyl, administered by trained endoscopist physician and nurse, represent a safe anesthetic alternative for endoscopic retrograde cholangiopancreatography. It allows procedures to be performed outside the operating room, thereby reducing costs.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 3","pages":"262-267"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490755/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Preand Post-Processing Evaluations of Manual and Automated Endoscopes: A Microbiological Isolation]. [人工和自动内窥镜的前后处理评价:微生物分离]。
Q4 Medicine Pub Date : 2024-09-30 eCollection Date: 2024-07-01 DOI: 10.52787/agl.v54i3.423
Romina Medeot, Javier Mena, Pablo Rodríguez, Pablo Herrera Najum, Luis López, María Soledad Muñoz

Introduction: An endoscope is a flexible tube equipped with a camera and a light used for the diagnosis and treatment of digestive pathologies. Although healthcare-associated infections are uncommon, they represent a significant concern. Proper endoscope reprocessing is essential to prevent infections, requiring adherence to established guidelines for cleaning, disinfection, and storage.

Objetive: To compare the effectiveness of manual and automated reprocessing of video gastroscopes and colonoscopes through microbiological monitoring of the following microorganisms: ESBL Escherichia coli, Shigella spp., Salmonella spp., Pseudomonas aeruginosa, Klebsiella pneumoniae carbapenemase (KPC)-producing, and vancomycin-resistant Enterococcus spp.

Materials and methods: A prospective, observational, descriptive study was conducted, in which 207 reprocessing procedures of video gastroscopes and colonoscopes were selected for evaluation. Of these, 103 were manual and 104 were automated. The procedures were evaluated in both the preand post-processing stages. Cultures were performed to isolate ESBL Escherichia coli, Shigella spp., Salmonella spp., Pseudomonas aeruginosa, Klebsiella pneumoniae carbapenemase (KPC)-producing, and vancomycin-resistant Enterococcus spp.

Results: In the pre-reprocessing samples, ESBL Escherichia coli was isolated in 45% of cases, compared to 55% for manual and automated reprocessing, respectively. Similarly, Pseudomonas aeruginosa was isolated in 36% of cases for manual reprocessing and 18% for automated reprocessing. Salmonella spp. was isolated in 18% of cases for both manual and automated reprocessing. Finally, vancomycin-resistant Enterococcus spp. was isolated in 9% of automated reprocessing samples. The results of the manual post-processing demonstrated that 1% of the samples exhibited counts of 1,000-99,999 colony-forming units (CFU)/ ml, while 6% exhibited counts exceeding 100,000 CFU/ml. The automated method demonstrated a 7% prevalence of samples with over 100,000 colony-forming units (CFU) per milliliter. A comparison of the two modalities revealed that pathogens were not identified in seven of the 103 manual samples and six of the 104 automated samples. The only growth observed in the automated samples was that of coagulase-negative Staphylococcus, which is a potential contaminant. However, one automated sample did yield Salmonella spp.

Conclusion: The results obtained were comparable between the two methodologies. The automated reprocessing revealed the presence of an enteropathogen, which will allow for a reassessment of the reprocessing steps in order to enhance the efficacy of the procedures.

内窥镜是一种装有照相机和灯的柔性管,用于诊断和治疗消化系统疾病。虽然与医疗保健相关的感染并不常见,但它们是一个重大问题。适当的内窥镜再处理对于预防感染至关重要,需要遵守既定的清洁、消毒和储存指南。目的:通过对ESBL大肠埃希氏菌、志贺氏菌、沙门氏菌、铜绿假单胞菌、肺炎克雷伯菌产碳青霉烯酶(KPC)和耐万古霉素肠球菌等微生物的微生物监测,比较人工和自动对视频胃镜和结肠镜再处理的效果。我们进行了一项前瞻性、观察性、描述性的研究,选取了207个视频胃镜和结肠镜的再处理程序进行评估。其中,103个是手动的,104个是自动的。在预处理和后处理阶段对这些程序进行了评估。培养分离出ESBL大肠埃希氏菌、志贺氏菌、沙门氏菌、铜绿假单胞菌、产碳青霉烯酶肺炎克雷伯菌和耐万古霉素肠球菌。结果:在预处理样品中,ESBL大肠埃希氏菌的分离率为45%,而手工和自动再处理样品的分离率分别为55%。同样,铜绿假单胞菌在36%的人工后处理病例和18%的自动后处理病例中被分离出来。在手工和自动再处理的病例中分离出18%的沙门氏菌。最后,在9%的自动再处理样品中分离出耐万古霉素肠球菌。人工后处理结果显示,1%的样品计数为1,000-99,999菌落形成单位(CFU)/ ml, 6%的样品计数超过100,000 CFU/ml。自动化方法显示7%的样品患病率超过100,000菌落形成单位(CFU)每毫升。两种方法的比较表明,103个人工样本中的7个和104个自动样本中的6个未发现病原体。在自动化样品中观察到的唯一生长是凝固酶阴性葡萄球菌,这是一种潜在的污染物。结论:两种方法的检测结果具有可比性。自动再处理显示存在肠病原体,这将允许对再处理步骤进行重新评估,以提高程序的有效性。
{"title":"[Preand Post-Processing Evaluations of Manual and Automated Endoscopes: A Microbiological Isolation].","authors":"Romina Medeot, Javier Mena, Pablo Rodríguez, Pablo Herrera Najum, Luis López, María Soledad Muñoz","doi":"10.52787/agl.v54i3.423","DOIUrl":"10.52787/agl.v54i3.423","url":null,"abstract":"<p><strong>Introduction: </strong>An endoscope is a flexible tube equipped with a camera and a light used for the diagnosis and treatment of digestive pathologies. Although healthcare-associated infections are uncommon, they represent a significant concern. Proper endoscope reprocessing is essential to prevent infections, requiring adherence to established guidelines for cleaning, disinfection, and storage.</p><p><strong>Objetive: </strong>To compare the effectiveness of manual and automated reprocessing of video gastroscopes and colonoscopes through microbiological monitoring of the following microorganisms: ESBL Escherichia coli, Shigella spp., Salmonella spp., Pseudomonas aeruginosa, Klebsiella pneumoniae carbapenemase (KPC)-producing, and vancomycin-resistant Enterococcus spp.</p><p><strong>Materials and methods: </strong>A prospective, observational, descriptive study was conducted, in which 207 reprocessing procedures of video gastroscopes and colonoscopes were selected for evaluation. Of these, 103 were manual and 104 were automated. The procedures were evaluated in both the preand post-processing stages. Cultures were performed to isolate ESBL Escherichia coli, Shigella spp., Salmonella spp., Pseudomonas aeruginosa, Klebsiella pneumoniae carbapenemase (KPC)-producing, and vancomycin-resistant Enterococcus spp.</p><p><strong>Results: </strong>In the pre-reprocessing samples, ESBL Escherichia coli was isolated in 45% of cases, compared to 55% for manual and automated reprocessing, respectively. Similarly, Pseudomonas aeruginosa was isolated in 36% of cases for manual reprocessing and 18% for automated reprocessing. Salmonella spp. was isolated in 18% of cases for both manual and automated reprocessing. Finally, vancomycin-resistant Enterococcus spp. was isolated in 9% of automated reprocessing samples. The results of the manual post-processing demonstrated that 1% of the samples exhibited counts of 1,000-99,999 colony-forming units (CFU)/ ml, while 6% exhibited counts exceeding 100,000 CFU/ml. The automated method demonstrated a 7% prevalence of samples with over 100,000 colony-forming units (CFU) per milliliter. A comparison of the two modalities revealed that pathogens were not identified in seven of the 103 manual samples and six of the 104 automated samples. The only growth observed in the automated samples was that of coagulase-negative Staphylococcus, which is a potential contaminant. However, one automated sample did yield Salmonella spp.</p><p><strong>Conclusion: </strong>The results obtained were comparable between the two methodologies. The automated reprocessing revealed the presence of an enteropathogen, which will allow for a reassessment of the reprocessing steps in order to enhance the efficacy of the procedures.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 3","pages":"254-261"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12310260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Gastrointestinal Disorders in Children with Autism Spectrum Disorders]. [自闭症谱系障碍儿童的胃肠道紊乱]。
Q4 Medicine Pub Date : 2024-09-30 eCollection Date: 2024-07-01 DOI: 10.52787/agl.v54i3.440
Cecilia Zubiri, Luciana Guzmán

Autism spectrum disorders are a group of core neurodevelopmental disorders that include deficits in social interaction and communication, repetitive behaviors, and sensory disorders. There is an increased frequency of gastrointestinal disorders in children with autism spectrum disorders compared to the population of neurotypical children. The factors involved in this increase in frequency are genetic, associated with an imbalance in the intestinal microbiota and dysfunction of the immune system. The most frecuently observed gastrointestinal disorders in these patients are constipation, abdominal pain, nausea and vomiting, food selectivity or allergy problems, abdominal distension, flatulence, aerophagia, diarrhea, fecal incontinence, enuresis and soiling. Children with autism spectrum disorders often have selective and restricted eating habits, resulting in an unbalanced diet that lacks essential nutrients, which contributes to the development of gastrointestinal disorders. In addition, they often have alterations in sensory processing that affect the perception of digestive symptoms or signals. Understanding and treating gastrointestinal disorders in children with autism spectrum disorders can be challenging. These patients require a comprehensive evaluation by a multidisciplinary team that includes pediatricians, gastroenterologists, psychologists, nutritionists, occupational therapists, therapeutic companions, neurologists and teachers. Relief of gastrointestinal symptoms in patients with autism spectrum disorders can improve sleep, appetite and eating patterns, increase energy levels and contribute to an overall sense of well-being. This improves behavior, cognitive function, and educational skills.

自闭症谱系障碍是一组核心神经发育障碍,包括社会互动和沟通缺陷、重复行为和感觉障碍。与神经正常的儿童相比,患有自闭症谱系障碍的儿童出现胃肠道疾病的频率更高。这种频率增加的因素是遗传的,与肠道微生物群的失衡和免疫系统的功能障碍有关。这些患者中最常见的胃肠道疾病是便秘、腹痛、恶心和呕吐、食物选择性或过敏问题、腹胀、胀气、食气、腹泻、大便失禁、遗尿和污秽。患有自闭症谱系障碍的儿童通常有选择性和限制性的饮食习惯,导致饮食不平衡,缺乏必需营养素,从而导致胃肠道疾病的发展。此外,他们通常在感觉处理过程中发生改变,从而影响对消化症状或信号的感知。理解和治疗自闭症谱系障碍儿童的胃肠道疾病可能具有挑战性。这些患者需要由包括儿科医生、胃肠病学家、心理学家、营养学家、职业治疗师、治疗同伴、神经科医生和教师在内的多学科团队进行全面评估。缓解自闭症谱系障碍患者的胃肠道症状可以改善睡眠、食欲和饮食模式,增加能量水平,并有助于整体幸福感。这可以改善行为、认知功能和教育技能。
{"title":"[Gastrointestinal Disorders in Children with Autism Spectrum Disorders].","authors":"Cecilia Zubiri, Luciana Guzmán","doi":"10.52787/agl.v54i3.440","DOIUrl":"10.52787/agl.v54i3.440","url":null,"abstract":"<p><p>Autism spectrum disorders are a group of core neurodevelopmental disorders that include deficits in social interaction and communication, repetitive behaviors, and sensory disorders. There is an increased frequency of gastrointestinal disorders in children with autism spectrum disorders compared to the population of neurotypical children. The factors involved in this increase in frequency are genetic, associated with an imbalance in the intestinal microbiota and dysfunction of the immune system. The most frecuently observed gastrointestinal disorders in these patients are constipation, abdominal pain, nausea and vomiting, food selectivity or allergy problems, abdominal distension, flatulence, aerophagia, diarrhea, fecal incontinence, enuresis and soiling. Children with autism spectrum disorders often have selective and restricted eating habits, resulting in an unbalanced diet that lacks essential nutrients, which contributes to the development of gastrointestinal disorders. In addition, they often have alterations in sensory processing that affect the perception of digestive symptoms or signals. Understanding and treating gastrointestinal disorders in children with autism spectrum disorders can be challenging. These patients require a comprehensive evaluation by a multidisciplinary team that includes pediatricians, gastroenterologists, psychologists, nutritionists, occupational therapists, therapeutic companions, neurologists and teachers. Relief of gastrointestinal symptoms in patients with autism spectrum disorders can improve sleep, appetite and eating patterns, increase energy levels and contribute to an overall sense of well-being. This improves behavior, cognitive function, and educational skills.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"54 3","pages":"231-238"},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12310266/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Gastroenterologica Latinoamericana
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1